Response to comment on "Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics". (2021)

First Author: Bovijn J
Attributed to:  China kadoorie biobank - University of Oxford funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.abf4530

PubMed Identifier: 34851696

Publication URI: http://europepmc.org/abstract/MED/34851696

Type: Journal Article/Review

Volume: 13

Parent Publication: Science translational medicine

Issue: 622

ISSN: 1946-6234